Wolchko J Scott 4

4 · FATE THERAPEUTICS INC · Filed Apr 25, 2022

Form 4

Period: 2022-04-21

See Remarks

Transactions

Exercise/Conversion
Common Stock
2022-04-21$2.70/sh+30,000$81,000→ 461,546 total
Sale
Common Stock
2022-04-22$34.54/sh−9,162$316,455→ 432,384 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-04-22$2.70/sh−10,000$27,000→ 36,246 total
Exercise: $2.70Exp: 2027-01-03→ Common Stock (10,000 underlying)
Sale
Common Stock
2022-04-21$34.57/sh−22,715$785,258→ 438,831 total
Sale
Common Stock
2022-04-21$35.73/sh−4,062$145,135→ 434,769 total
Sale
Common Stock
2022-04-21$37.90/sh−1,003$38,014→ 431,546 total
Sale
Common Stock
2022-04-21$36.70/sh−2,220$81,474→ 432,549 total
Exercise/Conversion
Common Stock
2022-04-22$2.70/sh+10,000$27,000→ 441,546 total
Sale
Common Stock
2022-04-22$35.15/sh−838$29,456→ 431,546 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-04-21$2.70/sh−30,000$81,000→ 46,246 total
Exercise: $2.70Exp: 2027-01-03→ Common Stock (30,000 underlying)

Footnotes (8)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
[F2]Represents the weighted average sale price of the shares sold from $34.22 to $35.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7.
[F3]Represents the weighted average sale price of the shares sold from $35.29 to $36.25 per share.
[F4]Represents the weighted average sale price of the shares sold from $36.29 to $37.08 per share.
[F5]Represents the weighted average sale price of the shares sold from $37.70 to $38.38 per share.
[F6]Represents the weighted average sale price of the shares sold from $34.04 to $35.03 per share.
[F7]Represents the weighted average sale price of the shares sold from $35.04 to $35.29 per share.
[F8]This option is fully vested.

Documents

1 file